IP Library Granted Patent US 9,357,932
Granted Patent B2
US 9,357,932 · App. 14/720,160 · Granted Jun 7, 2016

System and methods for wireless body fluid monitoring

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,357,932
App. No.
14/720,160
Granted
Jun 7, 2016
Kind
B2
Abstract

An adherent device to monitor a tissue hydration of a patient comprises an adhesive patch to adhere to a skin of the patient. A plurality of electrodes are connected to the patch and capable of electrically coupling to the patient. Circuitry is coupled to the plurality of electrodes to measure a tissue resistance of the patient at a first frequency and to detect a low frequency droop in the measured tissue resistance. In response to detected low frequency droop, the circuitry is configured to measure a tissue resistance of the patient at a second frequency that is lower than the first frequency to verify the detection of low frequency droop, and to temporarily suspend data collection based on the detection and verification of low frequency droop.

Claims (25)

1. A method of monitoring a patient, the method comprising:

adhering an adhesive patch to a skin of the patient to couple a plurality of electrodes to the skin of the patient to form a skin-electrode interface;

measuring a plurality of tissue resistances of the patient at a first frequency with impedance circuitry coupled to the plurality of electrodes;

detecting, with the impedance circuitry, a low frequency droop in the tissue resistance measurements made at the first frequency:

measuring, with the impedance circuitry, a tissue resistance of the patient at a second frequency, wherein the second frequency is lower than the first frequency;

verifying, with the impedance circuitry, the detection of low frequency droop based on the tissue resistance measured at the second frequency; and

temporarily suspending data collection with the impedance circuitry based at least in part on the fact that the low frequency droop has been detected and verified.

2. The method of claim 1 , wherein the first frequency is less than 100 kHz.

3. The method of claim 1 , wherein the first frequency is less than 20 kHz.

4. The method of claim 1 , wherein the second frequency is equal to about 2 kHz.

5. The method of claim 1 , wherein low frequency droop is detected when the measured tissue resistances at the first frequency declines by a threshold amount.

6. The method of claim 5 , wherein the threshold amount is a decline of more than 10%.

7. The method of claim 5 , wherein the threshold amount is a decline of more than 20%.

8. The method of claim 1 , further including calculating a change in patient body fluid based on the tissue resistance measured at the first frequency if no low frequency droop is detected.

9. An adherent device to monitor a tissue hydration of a patient, the device comprising:

an adhesive patch to adhere to a skin of the patient;

a plurality of electrodes connected to the patch and capable of electrically coupling to the patient; and

circuitry coupled to the plurality of electrodes to measure a plurality of tissue resistances of the patient at a first frequency and to detect a low frequency droop in the measured tissue resistances, wherein in response to detected low frequency droop, the circuitry is configured to measure a tissue resistance of the patient at a second frequency that is lower than the first frequency to verify the detection of low frequency droop, and to temporarily suspend data collection based on the detection and verification of low frequency droop.

10. The adherent device of claim 9 , wherein the first frequency is less than 100 kHz.

11. The adherent device of claim 9 , wherein the first frequency is less than 20 kHz.

12. The adherent device of claim 9 , wherein the second frequency is equal to about 2 kHz.

13. The adherent device of claim 9 , wherein the circuitry is configured to detect low frequency droop when the measured tissue resistances at the first frequency declines by a threshold amount.

14. The adherent device of claim 13 , wherein the threshold amount is a decline of more than 10%.

15. The adherent device of claim 13 , wherein the threshold amount is a decline of more than 20%.

16. The adherent deice of claim 9 , wherein the circuitry is further configured to calculate a change in patient body fluid based on the tissue resistance measured at the first frequency if no low frequency droop is detected.

Assignments (3)
CHANGE OF NAME Recorded Jul 10, 2015
From: MEDTRONIC CORVENTIS, INC.
To: MEDTRONIC MONITORING, INC.
Reel/Frame 036092/0333 →
MERGER AND CHANGE OF NAME Recorded Jul 9, 2015
From: CORVENTIS, INC.; MEDTRONIC CORVENTIS, INC.
To: MEDTRONIC CORVENTIS, INC.
Reel/Frame 036050/0703 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2015
From: LIBBUS, IMAD; BLY, MARK
To: CORVENTIS, INC.
Reel/Frame 036033/0847 →